Pennsylvania-based pharmaceutical company Endo Health Solutions has agreed to pay $193 million to settle claims that it engaged in illegal off-label marketing of its pain relief medication, Lidoderm. The company will pay $172 million to several states and the federal government to resolve whistleblower claims brought in the U.S. District Court for the Eastern District of Pennsylvania, and it will pay $21 million in criminal forfeiture and fines under a deferred prosecution agreement with the U.S. Attorney’s Office for the Northern District of New York, according to releases from the U.S. Department of Justice, the U.S. Attorney’s Office for the Eastern District of Pennsylvania and Endo Health Solutions. Plaintiffs Counsel: John R. Newcomer Jr., James, Hoyer, Newcomer & Smiljanich, Tampa, Fla., for Ryan; W.Scott Simmer, Blank Rome, Washington, D.C., for Weathersby; Phillip D. Barber and David Randolph Smith, David Randolph Smith & Associates, Nashville, Tenn., for Dhillon 
Is your employer defrauding the government?
Are you a former employee with information about fraud?
Are you a victim of fraud?
For nearly 150 years, the civil False Claims Act (“FCA”) has been a valuable instrument in the government’s efforts to combat fraud and protect the public treasury.
Do you have a whistleblower complaint? Click here to contact us for a confidential case review.
 For more information click here.